Treatment of shoulder spasticity in stroke patients using shock wave therapy
Official title: Effects of Extracorporeal Shock Wave Therapy on Shoulder Internal Rotator Spasticity in Post-Stroke Patients: A Randomized Controlled Trial
Run by National Taiwan University Hospital · NCT06674785 · Data updated 2026-11-12
This study is testing if shock wave therapy can help stroke patients with tight shoulder muscles feel better and move their arms more easily.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | July 23, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | July 29, 2025 |
| Trial ID | NCT06674785 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced a unilateral cerebral stroke and exhibit significant shoulder internal rotator spasticity.
✕Probably not a fit
Patients with a history of multiple strokes, other central nervous system disorders, or those who have recently received similar treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of focused extracorporeal shock wave therapy (ESWT) on shoulder internal rotator spasticity in patients who have suffered a stroke. Participants are randomly assigned to receive either the actual ESWT treatment or a placebo treatment that mimics the therapy. The treatment is administered twice weekly over two weeks, totaling four sessions, and various assessments are conducted to measure outcomes such as range of motion, pain levels, and functional abilities. The study aims to determine both the immediate and long-term effects of the therapy on shoulder function and spasticity.
Why it matters
Potential benefit: If successful, this therapy could significantly improve shoulder function and reduce spasticity in stroke survivors, enhancing their quality of life.
How similar studies have gone: Previous studies have shown promise for extracorporeal shock wave therapy in reducing spasticity, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older with unilateral cerebral stroke. * Restricted passive external rotation of the spastic shoulder by more than 20 degrees. * A Modified Ashworth Scale score of 1 or higher for shoulder internal rotator spasticity. * Stable medical condition and vital signs. * Clear consciousness, able to follow instructions. Exclusion Criteria: * History of two or more strokes, traumatic brain injury, brain tumors, or other cerebral disorders. * Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal conditions affecting muscle tone assessment. * Ineligibility for shock wave intervention due to malignancies, coagulation disorders, localized infections, or presence of a pacemaker. * Prior shock wave intervention or botulinum toxin injection for post-stroke spasticity within the past three months. * Inability to participate in interventions or functional assessments due to cognitive, consciousness, or language impairments.
Where it's running
-
Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Shu-mei Yang, MD — National Taiwan University Hospital
- Study coordinator: Shu-mei Yang, MD
- Email: b99401109@gmail.com
- Phone: 0972653675
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Tendon-lengthening surgery versus botulinum toxin injections for hand and wrist spasticity
This project tries to see if tendon-lengthening surgery helps adults with hand and wrist spasticity after stroke, spinal cord injury, or traumatic brain injury more than ongoing botulinum toxin injections.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.